Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 77,769 shares at $9.67 ($752K) on 2010-10-07, disclosed to the SEC on 2010-10-08.
Scheduled sale ($752k) by VP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.67 | 70,000 | $677K | 90.0% |
| 2 | $9.73 | 7,769 | $76K | 10.0% |
| Total | $9.68 avg | 77,769 | $752K | 100% |
| Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |
| PLX | SELL | 2009-07-08 | $255K | — | Filing → |